Assessment of Admission to the ICU of Onco-hematological Patients.

• Sponsor: University Hospital A Coruña (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT06113601
• Collaborator: (none)
• Enrollment: 800
• Anticipated Duration (Months): 8

Study Details

Study Description

Brief Summary

Multicenter, observational and prospective study.

Condition or Disease	Intervention/Treatment	Phase
Hematological Diseases; Critical Illness	Other: There is no intervention.

Detailed Description

The data collection period will include 6 consecutive months, starting from the date of acceptance or conformity of the CEIC. Or, until an adequate sample size is reached that guarantees the statistical relevance of said analysis. All patients will subsequently be followed up 3 months after discharge from the ICU.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 800 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Assessment of Admission to the ICU of Onco-hematological Patients. Income Patterns and Results.
• Anticipated Study Start Date: Jan 1, 2024
• Anticipated Primary Completion Date: Jul 1, 2024
• Anticipated Study Completion Date: Sep 1, 2024

Arms and Interventions

Arm	Intervention/Treatment
Patients admitted to the ICU.	Other: There is no intervention.; There is no intervention in the study.
Patients who are not admitted to the ICU.	Other: There is no intervention.; There is no intervention in the study.

Outcome Measures

Primary Outcome Measures

1. Hospital mortality. [During the 6 months of the study.]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All

Inclusion Criteria:

• Adults

• Solid organ tumor or hematological malignancy,

Exclusion Criteria:

-under 18 years old

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• University Hospital A Coruña

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Elena Cuenca Fito, Principal Investigator, University Hospital A Coruña
• ClinicalTrials.gov Identifier: NCT06113601
• Other Study ID Numbers: 23772377
• First Posted: Nov 2, 2023
• Last Update Posted: Nov 2, 2023
• Last Verified: Oct 1, 2023

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Hematologic Diseases; Critical Illness

Study Results

No Results Posted as of Nov 2, 2023